Five Prime Thera
(FPRX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2014 | 06-2014 | 03-2014 | 12-2013 | 09-2013 | |
| Sales | 6,059 | 4,981 | 3,546 | 3,785 | 3,482 |
| Gross Profit | 6,059 | 4,981 | 3,546 | 3,785 | 3,482 |
| Operating Expenses | 13,163 | 14,897 | 12,206 | 11,119 | 10,800 |
| Operating Income | -7,104 | -9,916 | -8,660 | -7,334 | -7,318 |
| Other Income | 16 | 50 | 16 | 17 | 84 |
| Pre-tax Income | -7,088 | -9,866 | -8,644 | -7,317 | -7,234 |
| Net Income Continuous | -7,088 | -9,866 | -8,644 | -7,317 | -7,234 |
| Net Income | $-7,088 | $-9,866 | $-8,644 | $-7,317 | $-7,234 |
| EPS Basic Total Ops | -0.33 | -0.46 | -0.46 | 9.06 | -2.74 |
| EPS Basic Continuous Ops | -0.33 | -0.46 | -0.46 | 9.07 | -2.74 |
| EPS Diluted Total Ops | -0.33 | -0.46 | -0.46 | 9.06 | -2.74 |
| EPS Diluted Continuous Ops | -0.33 | -0.46 | -0.46 | 9.07 | -2.74 |
| EBITDA(a) | $-6,275 | $-9,118 | $-8,058 | $-6,768 | $-6,822 |